Final date to apply is Feb. 1
News
The life-changing impact of clinical trials
“OMRF has saved my life,” says MS patient Tonja Martin.
OMRF scientist receives $300,000 from Lupus Research Alliance
The Lupus Research Alliance is the world’s leading private funder of lupus research.
New use for OMRF brain cancer treatment could extend lives
In a new study, the OMRF compound OKN-007 is being combined with the current standard-of-care medication for glioblastoma.
OMRF scientists discover potential therapeutic target for lymphedema
Lymphedema is a disease characterized by dramatic and painful swelling in the limbs that often leads to infections.
OMRF named Oklahoma’s top workplace
We have now won the top prize two of the past three years.